Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology
Authors:
- 16 June 2021
- journal article
- research article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 52 (6) , 507-518
Abstract
Introduction: A working group on the Oxford classification of IgA nephropathy (IgAN) recently reported that crescents detected in the kidney tissue predicted a worse renal outcome. However, the effect of C1 lesion (crescents in Methods: We investigated 305 biopsy-proven IgAN patients without obvious chronic renal lesions. Clinicopathologic features and treatment modalities were recorded. The patients were divided into several groups according to the presence or absence of a global crescent: no crescent (NC) group, only segmental crescent (SC) group, and global crescent (GC) group. The outcome was the survival from a combined event defined by a ≥15% decline in the estimated glomerular filtration rate (eGFR) after 1 year or ≥30% decline in the eGFR after 2 years. Results: Among all patients, 75.7% were in the NC group, 14.8% were in the SC group, and 9.5% were in the GC group. Compared with the NC group, patients in the SC group and the GC group had more urine protein, lower eGFR, and presented with more severe pathological change. During a median follow-up of 34.8 (26.16–57.95) months, the combined event occurred in 34 individuals (11.1%). In a multivariate model, the GC group (HR = 2.756, 95% CI = 1.068–7.109) was associated with an increased risk of the combined event. Conclusions: In IgAN patients without obvious chronic renal lesions, the GC group had more severe clinical and pathological manifestations than in the NC group. GC is an independent risk factor for the progression of IgAN renal function.Keywords
This publication has 16 references indexed in Scilit:
- A Multicenter Study of the Predictive Value of Crescents in IgA NephropathyJournal of the American Society of Nephrology, 2016
- Candidate Surrogate End Points for ESRD after AKIJournal of the American Society of Nephrology, 2016
- Intensive Supportive Care plus Immunosuppression in IgA NephropathyNew England Journal of Medicine, 2015
- Clinical Outcomes of IgA Nephropathy Patients with Different Proportions of CrescentsHong Kong Journal of Nephrology, 2015
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and MortalityJAMA, 2014
- Clinical implication of crescentic lesions in immunoglobulin A nephropathyNephrology Dialysis Transplantation, 2013
- A Multicenter Application and Evaluation of the Oxford Classification of IgA Nephropathy in Adult Chinese PatientsAmerican Journal of Kidney Diseases, 2012
- Validation Study of Oxford Classification of IgA NephropathyClinical Journal of the American Society of Nephrology, 2011
- The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibilityKidney International, 2009
- Influence of Serum High-Molecular-Weight and Total Adiponectin on Arteriosclerosis in IgA Nephropathy PatientsNephron Clinical Practice, 2008